Xavier Tekpli
Impact in
- Cancer Research top 5%
- Carcinogens and Genotoxicity Assessment
-
- Toxic Organic Pollutants Impact
- Air Quality and Health Impacts
Papers in
-
- Cancer Genomics and Diagnostics 4
- Co-authors
- Dominique Lagadic‐GossmannJørn A. HolmeOdile SergentMarie‐Thérèse Dimanche‐BoitrelNina E. LandvikMorgane GorriaMary RisselVessela N. Kristensen
- Journals
- International Journal of Cancer (4 papers)Toxicology and Applied Pharmacology (4 papers)OncoImmunology (3 papers)Scientific Reports (2 papers)Bioinformatics (2 papers)
- Partner nations
- NorwayFranceUnited States
In The Last Decade
Xavier Tekpli
49 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 118
- Cancer Research 312
- Health, Toxicology and Mutagenesis 175
- Biochemistry 89
- Molecular Biology 793
- Oncology 221
Countries citing papers authored by Xavier Tekpli
This map shows the geographic impact of Xavier Tekpli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Tekpli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Tekpli more than expected).
Fields of papers citing papers by Xavier Tekpli
This network shows the impact of papers produced by Xavier Tekpli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Tekpli. The network helps show where Xavier Tekpli may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xavier Tekpli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 9 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 10 | |
| 7 | 2021 | 8 | |
| 8 | 2021 | 3 | |
| 9 | 2021 | 38 | |
| 10 | 2020 | 14 | |
| 11 | 2016 | 8 | |
| 12 | 2012 | 65 | |
| 13 | 2012 | 82 | |
| 14 | 2011 | 49 | |
| 15 | 2011 | 24 | |
| 16 | 2010 | 41 | |
| 17 | 2008 | 27 | |
| 18 | 2008 | 40 | |
| 19 | 2007 | 31 | |
| 20 | 2007 | 131 |
About Xavier Tekpli
Xavier Tekpli is a scholar working on Cancer Research, Biochemistry, Oncology, Molecular Biology and Immunology, having authored 50 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (6 papers), Epigenetics and DNA Methylation (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Ion Transport and Channel Regulation (4 papers), Cancer Genomics and Diagnostics (4 papers), Lipid Membrane Structure and Behavior (4 papers), HER2/EGFR in Cancer Research (3 papers) and Caveolin-1 and cellular processes (3 papers). The work is most often cited by research in Cancer Research (312 citations), Health, Toxicology and Mutagenesis (175 citations), Biochemistry (89 citations), Molecular Biology (793 citations) and Oncology (221 citations). Xavier Tekpli has collaborated with scholars based in Norway, France and United States. Frequent co-authors include Dominique Lagadic‐Gossmann, Jørn A. Holme, Odile Sergent, Marie‐Thérèse Dimanche‐Boitrel, Nina E. Landvik, Morgane Gorria, Mary Rissel, Vessela N. Kristensen, Aage Haugen and Shanbeh Zienolddiny. Their work appears in journals such as International Journal of Cancer, Toxicology and Applied Pharmacology, OncoImmunology, Scientific Reports and Bioinformatics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.